Delivery Order SPE2DE21D7009-SPE2D626F7A92
- Not listed
- The Defense Logistics Agency Troop Support Medical branch awarded a delivery order valued at $42,752.40 to Boston Scientific Neuromodulation Corp on December 31, 2025, for the delivery of a Kit NRSTM WaveWriter Alpha with 10.7mm thickness (quantity 200). This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by March 30, 2026, and will be performed at the contractor's facility in Valencia, California. The award carries no small business set-aside...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a $1,867 fixed-price delivery order with economic price adjustment authority for pain management medical devices, with a completion date of March 2, 2026. The contract was awarded on December 15, 2025, by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Work will be performed at the company's facility in Valencia, California. This delivery order is issued under...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a fixed-price delivery order valued at $31,408.96 for pain management medical devices and equipment. The contract, awarded on July 24, 2025, with an ultimate completion date of July 31, 2025, carries no set-aside designation and will be performed in Valencia, California. The award is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,825.75 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment authority is performance-based in Valencia, California, and carries an ultimate completion date of December 5, 2025. The contract was awarded by the Medical Supply Chain, a defense-related procurement entity under the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $40,769.27 fixed price delivery order with economic price adjustment for pain management medical devices on December 19, 2025, with an ultimate completion date of December 29, 2025. The contract is funded by the Medical Supply Chain, a defense-related procurement entity, and performance will be conducted in Valencia, California. This delivery order represents work issued under Boston Scientific...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $42,456.67 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment provisions falls under the larger Defense Logistics Agency Troop Support Medical indefinite delivery contract (SPE2DE) valued at $83.1 million and running through August 16, 2026. The award carries no small business set-aside...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F7A92Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $43,751.07 fixed-price delivery order on December 31, 2025, for a Kit NRSTM WaveWriter Alpha medical device with a 10.7mm thickness. The work is set to conclude by March 30, 2026, with performance occurring in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger Single-Award Indefinite Delivery Contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at approximately $83.1 million through August 2026. The Medical Supply Chain, a defense-related procurement entity under the Department of Defense, is providing the funding for this delivery order. The WaveWriter Alpha device represents an advanced spinal cord stimulation system developed through Boston Scientific's commitment to non-opioid pain management solutions for military service members and veterans. This delivery order continues the company's established role as a primary supplier of neuromodulation technologies and pain management devices to military treatment facilities and Veterans Affairs medical centers nationwide. No small business set-aside was applied to this award, allowing Boston Scientific to compete on an unrestricted basis. The parent company's extensive federal portfolio, including a $750,000 Blanket Purchase Agreement with the Defense Health Agency for radiation treatment devices, underscores Boston Scientific's position as a critical supplier of specialized medical technologies to federal healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.8k | 12/30/25 |